Skip to main content

CORRECTION article

Front. Psychiatry, 20 December 2019
Sec. Schizophrenia
Volume 10 - 2019 | https://doi.org/10.3389/fpsyt.2019.00908

Corrigendum: Nerve Growth Factor Serum Levels Are Associated With Regional Gray Matter Volume Differences in Schizophrenia Patients

This article is a correction to:

  1. Nerve Growth Factor Serum Levels Are Associated With Regional Gray Matter Volume Differences in Schizophrenia Patients

    1. Read original article
Kristina Neugebauer,*Kristina Neugebauer1,2*Christine Hammans,Christine Hammans1,2Tobias WensingTobias Wensing1Vinod Kumar,,Vinod Kumar1,2,3Wolfgang GroddWolfgang Grodd3Lea Mevissen,Lea Mevissen1,2Melanie A. Sternkopf,Melanie A. Sternkopf1,2Ana Novakovic,Ana Novakovic1,2Ted AbelTed Abel4Ute Habel,Ute Habel1,2Thomas Nickl-Jockschat,,,Thomas Nickl-Jockschat1,2,4,5
  • 1Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, RWTH Aachen University, Aachen, Germany
  • 2Jülich-Aachen Research Alliance, Jülich, Germany
  • 3Max-Planck-Institute for Biological Cybernetics, Tübingen, Germany
  • 4Iowa Neuroscience Institute, University of Iowa, Iowa City, IA, United States
  • 5Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, IA, United States

A Corrigendum on
Nerve Growth Factor Serum Levels Are Associated With Regional Gray Matter Volume Differences in Schizophrenia Patients

by Neugebauer K, Hammans C, Wensing T, Kumar V, Grodd W, Mevissen L, Sternkopf MA, Novakovic A, Abel T, Habel U and Nickl-Jockschat T (2019). Front. Psychiatry. 10:275. doi: 10.3389/fpsyt.2019.00275

In the original article, there was an error. The Author Contributions statement misrepresents the contributions of TN-J, KN, TW, TA, WG, and UH.

A correction has been made to Author Contributions:

“TN-J contributed to the conception and design of the study, and supervised data acquisition, analysis, and interpretation, as well as manuscript proofreading. LM, MS, and AN conducted informed consent. WG arranged MRI settings. KN, TW, and VK performed analysis of the MRI data. KN contributed to data acquisition, analysis, interpretation, and wrote the manuscript. CH contributed to data acquisition. TW, TA, WG, and UH contributed to manuscript proofreading.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: schizophrenia, nerve growth factor, voxel-based morphometry, neuroimaging, functional decoding

Citation: Neugebauer K, Hammans C, Wensing T, Kumar V, Grodd W, Mevissen L, Sternkopf MA, Novakovic A, Abel T, Habel U and Nickl-Jockschat T (2019) Corrigendum: Nerve Growth Factor Serum Levels Are Associated With Regional Gray Matter Volume Differences in Schizophrenia Patients. Front. Psychiatry 10:908. doi: 10.3389/fpsyt.2019.00908

Received: 13 November 2019; Accepted: 15 November 2019;
Published: 20 December 2019.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2019 Neugebauer, Hammans, Wensing, Kumar, Grodd, Mevissen, Sternkopf, Novakovic, Abel, Habel and Nickl-Jockschat. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Kristina Neugebauer, kneugebauer@ukaachen.de

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.